Abstract:Although there are currently fewer than one hundred kinds of antiviral drugs,the virus infection can't be cured completely.These drugs are used for the treatment of human immunodeficiency virus,hepatitis B virus,cytomegalovirus,herpes simplex virus,influenza virus,hepatitis C virus infection,etc.Peptides were first discovered as a component of innate immune system against microbial invasion.A series of natural biological peptides with antitumor,antiviral or antibacterial activities in animals,plants and microorganisms have been studied in recent years.Anti-bacterial peptides exhibit broad inhibition effect by destroying the membrane of bacterial and leading to the leakage of content.Peptides attracted more attentions for their high activities and less drug-resistance.Many potential peptides are being developed into drugs,but they are also limited by high price,poor stability and less source.There are few peptide drugs in clinical experiment.The recent advances of polypeptide molecular drugs and their targets,involving anti-herpes simplex virus (HSV),human immunodeficiency virus (HIV),influenza virus A (IVA) and hepatitis C virus (HCV) peptides were summarized.Their antiviral activity and mechanism were also elucidated.Peptides with antiviral activity can be divided into three main groups.Firstly,entry blocker peptides bind to virus glycoprotein and prevent virus-cell fusion.Second,peptides exhibit virucidal activity by disrupting viral envelopes.Finally,a third set of peptides interact with host cells and modulate immune response.The balance between hydrophobicity and the charge is an important marker of possible therapeutical application of peptides as well as amphipaticity and molecular mass.The appropriate peptide candidates should have low toxicity and high selectivity.Up to date,antiviral activities and mechanisms of peptides have been comprehensively studied.Here,we present a review of the current literature describing the antiviral peptides and provide suggestions for the study of antiviral peptide drugs.

Discovery and development of antiviral drugs

Current Progress in Antiviral Strategies.

Clinical Applications of Antiviral Agents

Virology research and development of antiviral drugs

Latest progress in the development of anti-2019-nCoV therapeutic drugs

New perspective of small-molecule antiviral drugs development for RNA viruses

Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H

Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics

A Route to Novel Antiviral Agents and New Therapeutic Approaches

Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge Technology

A Mini-Review on the Common Antiviral Drug Targets of Coronavirus

Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses

The Research Progress of Antiviral Peptides

Development of Broad-Spectrum Antiviral Agents—Inspiration from Immunomodulatory Natural Products

Antivirals with common targets against highly pathogenic viruses

Natural products as potential lead compounds to develop new antiviral drugs over the past decade

An overview of functional nanoparticles as novel emerging antiviral therapeutic agents

Selected Milestones in Antiviral Drug Development

Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday

Anti-virus reagents targeting the capsid protein assembly

Systematic Optimization of Host-Directed Therapeutic Targets and Preclinical Validation of Repositioned Antiviral Drugs